(Q33875656)

29 July 2017

title

Apparent and true resistant hypertension: definition, prevalence and outcomes (English)

1 reference

29 July 2017

main subject

arterial hypertension

0 references

author name string

E Judd

series ordinal

1

1 reference

29 July 2017

D A Calhoun

series ordinal

2

1 reference

29 July 2017

publication date

16 January 2014

1 reference

Journal of Human Hypertension

29 July 2017

published in

1 reference

29 July 2017

volume

28

1 reference

29 July 2017

issue

8

1 reference

29 July 2017

page(s)

463-468

1 reference

https://scigraph.springernature.com/pub.10.1038/jhh.2013.140

29 July 2017

exact match

0 references

cites work

Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4090282

Resistant hypertension--its identification and epidemiology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4090282

Incidence and prognosis of resistant hypertension in hypertensive patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4090282

Refractory hypertension: definition, prevalence, and patient characteristics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4090282

Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4090282

Epidemiology of resistant hypertension

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4090282

Prognostic influence of office and ambulatory blood pressures in resistant hypertension

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4090282

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4090282

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4090282

Worldwide prevalence of hypertension: a systematic review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4090282

Hypertension treatment and control in five European countries, Canada, and the United States

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4090282

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4090282

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4090282

Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4090282

Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States

5 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.140

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.140

High prevalence and poor control of hypertension in primary care: cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.140

Blood pressure control in Italian essential hypertensives treated by general practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.140

Apparent and true resistant hypertension: why not the same?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.140

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.140

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.140

Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.140

Prevalence of resistant hypertension in the United States, 2003-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.140

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.140

Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.140

The effect of a losartan-based treatment regimen on isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.140

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4090282

Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trials

29 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2013.140

US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008

21 January 2018

1 reference

12 December 2020

Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring

1 reference

12 December 2020

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group

1 reference

12 December 2020

Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension

1 reference

12 December 2020

Continued Improvement in Hypertension Management in England

1 reference

12 December 2020

Resistant hypertension? Assessment of adherence by toxicological urine analysis

1 reference

12 December 2020

Identifiers

DOI

10.1038/JHH.2013.140

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference